Actio gets $66M for experimental epilepsy and Charcot-Marie-Tooth treatments
An impressive group of biopharma investors put $66 million into a San Diego startup called Actio Biosciences. The clinical-stage company said Wednesday morning that existing investor Deerfield Management and new backer Regeneron Ventures co-led Actio' ...
An impressive group of biopharma investors put $66 million into a San Diego startup called Actio Biosciences.
The clinical-stage company said Wednesday morning that existing investor Deerfield Management and new backer Regeneron Ventures co-led Actio' ...
